glp 1 agonist review GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes Cardiovascular Effects and Tolerability of

Li said the best way to manage weight is to focus on lifestyle choices

4,6 A key issue in the physiology of type 2 diabetes (T2DM) is the reduced incretin effect, which mainly results from decreased activity of the primary incretin hormones, GLP-1 (glucagon-like peptide 1) and GIP (glucose-dependent insulinotropic peptide)

In humans, neuroimaging studies show associative evidence that GLP-1 agonists alter brain responses to food cues, potentially dampening the neural reactivity to appetizing foods that may trigger binge episodes in susceptible individuals

Effects of the novel long-acting GLP-1 agonist, albiglutide, on cardiac function, cardiac metabolism, and exercise capacity in patients with chronic heart failure and reduced ejection fraction

174 Currently, Eli Lilly has initiated a Phase III development program to further investigate the efficacy and safety of orforglipron in treating obesity, overweight, and T2DM

Evidence from both preclinical and clinical studies supports their antiinflammatory roles in the cardiovascular system, liver, kidneys, and joints